ArticleJournal of animal science and biotechnology2025
Dihydrosanguinarine enhances tryptophan metabolism and intestinal immune function via AhR pathway activation in broilers.
Article in Journal of animal science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Dietary Sanguinarine MitigatesLife (Basel, Switzerland) · 2026Article
- Dihydrosanguinarine: A Review of Its Pharmacology, Structure-Activity Relationship, Toxicity, Pharmacokinetics, and Clinical Prospects.International journal of molecular sciences · 2026Review
- Gut microbiome and postbiotics: bridging the dietary nutrition and feed efficiency in food-producing animals.Science China. Life sciences · 2025Review
- Neutral Sodium Humate Modulates Growth, Slaughter Traits, Antioxidant Status, and Gut Health in Yellow-Feathered Broilers.Animals : an open access journal from MDPI · 2025Article
- The AhR/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects.Frontiers in immunology · 2025Review
- Microbial metabolites and their influence on the tumor microenvironment.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTryptophan is essential for nutrition, immunity and neural activity, but cannot be synthesized endogenously. Certain natural products influence host health by modulating the gut microbiota to promote the production of tryptophan metabolites. Sanguinarine (SAN) enhances broiler immunity, however, its low bioavailability and underlying mechanisms remain unclear. This study aimed to decode the mechanisms by which sanguinarine enhances intestinal immune function in broilers.
methodsLiquid chromatography-tandem mass spectrometry (LC-MS/MS) was employed to identify the main metabolites of sanguinarine in the intestine. Subsequently, equal concentrations of sanguinarine and its metabolites were separately added to the diets. The effects of sanguinarine and its metabolites on the intestinal immune function of broiler chickens were evaluated using 16S rRNA gene amplicon sequencing and tryptophan metabolomics approaches.
resultsWe determined that dihydrosanguinarine (DHSA) is the main metabolite of sanguinarine in the intestine. Both compounds increased average daily gain and reduced feed efficiency, thereby improving growth performance. They also enhanced ileal villus height and the villus-to-crypt (V/C) ratio while decreasing crypt depth and upregulating the mRNA expression of tight junction proteins ZO-1, occludin and claudin-1. Furthermore, both compounds promoted the proliferation of intestinal Lactobacillus species, a tryptophan-metabolizing bacterium, stimulated short-chain fatty acid production, and lowered intestinal pH. They regulated tryptophan metabolism by increasing the diversity and content of indole tryptophan metabolites, activating the aryl hydrocarbon receptor (AhR) pathway, and elevating the mRNA levels of CYP1A1, CYP1B1, SLC3A1, IDO2 and TPH1. Inflammatory cytokines IL-1β and IL-6 were inhibited, while anti-inflammatory cytokines IL-10 and IL-22, serum SIgA concentration, and intestinal MUC2 expression were increased. Notably, DHSA exhibited a more pronounced effect on enhancing immune function compared to SAN.
conclusionsSAN is converted to DHSA in vivo, which increases its bioavailability. DHSA regulates tryptophan metabolism by activating the AhR pathway and modulating immune-related factors through changes in the gut microbiota. Notably, DHSA significantly increases the abundance of Lactobacillus, a key tryptophan-metabolizing bacterium, thereby enhancing intestinal immune function and improving broiler growth performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.